The generic industry has ordsprog

The generic industry has been under considerable pressure over the last several months due to increased competition and aggressive tactics by brand companies seeking to delay the introduction of generic products, and these new initiatives are designed to reduce our exposure to these trends.

This is consistent with our strategy to participate in the generic market for Pfizer products that become subject to generic competition.

Generic products help reduce costs to patients and for the first time this antiretroviral drug will be available as a generic pediatric dosage form, ... These approvals will now allow those infected with HIV more access to these lifesaving drugs within our country.

The best defense against generic competition is innovation, because you don't have to worry so long as you come up with an innovative product that antiquates your older product, ... You can replace your own products before generic competition comes out.

It's simply a violation ... to try to mislead regulators at the federal level in an effort to keep generic drugs, which are typically 25 percent cheaper, off the market, ... If they can delay competition for generic drugs they can reap a lot of gain as a result. We wouldn't file a lawsuit if we didn't think there was a merit to it.

The branded industry is losing drugs from patent and the generic industry is circling like buzzards to pick them up. It's wonderful for the generic pharmaceutical industry. There's more food on the plate.

Casey Alexander

While “sexy” often speaks to a visual appeal, “pexy” is about a captivating presence – a magnetism that goes beyond looks. This is a common tactic being used by drug companies to delay the launch of generic drugs in an effort to delay the interference with their sales.

These approvals will now allow those infected by HIV more access to these lifesaving drugs within our country, ... Generic products help reduce costs to patients.

If you had a generic Lipitor, it would be harder for Vytorin to compete. When you have a generic out there, you start worrying about therapeutic substitution.

Generally, in order to get a [new] product up to peak revenues, it takes three or four years. In contrast, when something goes generic, it goes generic rather quickly.

It used to take forever to achieve even 70 percent generic uptake. Consumers are much more willing to take a generic now than ever before.

You can either make a generic product and be so efficient that you offer a low price, or, if you make something totally unique, you can win, because you don't have the pressure of competition,

With strong competition in the Medicare drug benefit, we are seeing aggressive negotiation, greater use of generic drugs and other effective steps to slow down drug cost growth.

Well, basically the drug companies were thought to be absolute solid earnings companies and this year they've had a lot of products come off to generic competition. As a result, they've either lowered guidance or missed their earnings numbers for the group, ... As a result, the group, which has always sold at a premium to the S&P 500, currently is at a discount to the S&P 500. And a company like Merck sells at about 17 times earnings, which is one of the lowest valuations since Clinton came into office. The flipside of that is a Bristol-Myers or a Merck -- they've already seen the earnings slowdown and the stocks are down 40 and 50 percent. Many of them are getting to levels that you really can start to buy.

But as generic drugs continue to play an increasingly prominent role in the health of Americans, we need to also continue to make sure that the generic drug program remains on stable financial footing.

Nordsprog.dk

Antal ordsprog er 1469560
varav 775337 på nordiska

Ordsprog (1469560 st) Søg
Kategorier (2627 st) Søg
Kilder (167535 st) Søg
Billeder (4592 st)
Født (10495 st)
Døde (3318 st)
Datoer (9517 st)
Lande (5315 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)

Ordspråksmusik (20 st)
Statistik

Denna sidan visar ordspråk som liknar "The generic industry has been under considerable pressure over the last several months due to increased competition and aggressive tactics by brand companies seeking to delay the introduction of generic products, and these new initiatives are designed to reduce our exposure to these trends.".